INVION LIMITED — Major Shareholding Notification 2010

Feb 24, 2010

25 February 2010

The Manager Company Announcements Office ASX Limited 20 Bridge St SYDNEY NSW 2000

Dear Sir,

NOTICE OF INITIAL SUBSTANTIAL HOLDER

Please find attached a Form 603- Notice of Initial Substantial Shareholder which has been received by the Company today.

For and on behalf of the Board

BEN GRAHAM Company Secretary

$\ddot{\phantom{a}}$

$\mathbf{I}$

Form 603

Corporations Act 2001

Section 671B

Notice of initial substantial holder

To Company Name/Scheme	CBio Limited
ACN/ARSN	094 730 417
1. Details of substantial holder (1)
Name ACN/ARSN (if applicable)	COOUTOr Michael Monsour פסחוטם
The holder became a substantial holder on	10/02/2010

2 Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

. Class of securities (4)	Number of securities	Person's votes (5)	Voting power (6)
∩⊓⊡⊡UOrdinary shares	∪∩∩ഥ08,757,433	8,757,433	ഗ്രനമ ്വ 12%
	Ieneou	ססממו	looon

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

тыв дэ минин.
Holder of relevant interest	Nature of relevant interest (7)	Class and number of securities
MPAMM Pty Ltd	Innocusemental owner	4.134.074 ordinary shares
M P Monsour Medical Practice Super	Innocederation owner	1,050,208 ordinary shares
Fund Australian Technology Innovation Fund	Director & shareholder	3,373,598 ordinary shares
Limited Australian Biofund Investments Limited	Director & shareholder	199,553 ordinary shares

4. Details of present registered holders

-
believe of the securities referred to in paragraph 3 above are as follows: The persons regis

$\frac{1}{2}$	Registered holder of	Person entitled to be	Class and number
Holder of relevant	securities	registered as holder (8)	of securities
interest DOUGHOr Michael Monsour	IMPAMM Pty Ltd	IMPAMM Pty Ltd	4,134,074 ordinary Shares
Dr Michael Monsour	M P Monsour Medical Practice	IM P Monsour Medical Practice	1,050,208 ordinary
	Super Fund	Super Fund	shares
Dr Michael Monsour	Technology Australian Innovation Fund Limited	Technology Australian Imnovation Fund Limited	3.373.598 ordinary shares
Dr Michael Monsour	Australian Biofund Investments	Australian Biofund Investments	199,553 ordinary
	Limited	Limited	shares

The consideration pald for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

ATBU NOIDET IS 85 IUNUWS. Holder of relevant	Date of acquisition cocou	Consideration (9)		Class and number of securities
mlerest		Cash	Non-cash	kmooo
هووين CUORCMPAMM PTY LTD	8 November 2009	IULIN\$890,40700		1,780.814 ordinary Ishares
M P Monsour Medical Practice	6 November 2009	IS82.928		165,856 ordinary ishares
Super Fund COLUMPAMM PTY LTD	9 November 2009	B235,325UUDDD		k70.650 ordinary Ishares
M P Monsour Medical Practice	9 November 2009	ង24.970		49,940 ordinary ishares
Super Fund IDUORDMPAMM PTY LTD	8 February 2010	5300.00000DDCU		300,000 ordinary Ishares

MUNSUURCLINIC

page 2/2 15 July 2001 603

Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
MPAMM Pty Ltd	Dr Monsour is the beneficial owner
M P Monsour Medical Practice Super	Dr Monsour is the beneficial owner
Fund	Australian Technology Innovation Fund [01113GDr Monsour is a director and shareholderTT
Limited	COUGOr Monsour is a director and shareholderD
Australian Biofund Investments Limited

7. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Dr Michael Monsour	COOD0297 Kent Street Maryborough Qld 4065
MPAMM Pty LId	nnDDD297 Kent Street Maryborough Old 4065
M P Monsour Medical Practice Super Fund	OCITIZIZ97 Kent Street Maryborough Qid 4085
Australian Technology Innovation Fund Limited	85 Brand) St Eight Mile Plains Qld 4113
Australian Biofund Investments Limited	PO Box 3104 South Brisbane 4101

Signature

	print name Dr. Michael Monsour	٠	capacity	nouuc
sign here	W/	monosa	date	25000 002000U U/2010000ULI
		DIRECTIONS

If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, $(1)$ they may be referred to throughout the form as a specifically named group if the membership of each group, with the rames and addresses of members is clearly set out in paragraph 7 of the form.

• See the definition of "associate" in section 9 of the Corporations Act 2001. $(2)$
• See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001. $(3)$
• The voting shares of a company constitute one class unless divided into separate classes. $(4)$
• The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a $(5)$ relevant interest in.
• The person's votes divided by the total votes in the body corporate or scheme multiplied by 100. 76)
• Include details of, $\sigma$
• any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 6718(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme $(e)$ or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
• any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (Indicating clearly the particular securities to which the qualification applies). (b)

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown." $(8)$